Back to Journals » Biologics: Targets and Therapy » Volume 12

Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway

Total article views   Abstract views HTML views PDF downloads Totals
6,500 Dovepress* 4,992 862+ 748 5,854
PubMed Central* 0 646 265 646
Totals 4,992 1,508 1,013 6,500
*Since 20 August 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 1 1 4

View citations on PubMed Central and Google Scholar